Pure Global AI
ANVISA registration 80102512669Active

ANTI-ADALIMUMAB ANTIBODIES (ADL)

ANVISA Registration Number: 80102512669VR MEDICAL IMPORTADORA E DISTRIBUIDORA DE PRODUTOS MÉDICOS LTDABUHLMANN LABORATORIES AGRisk Class II
Verified
Device names
Technical name
ANTI-ADALIMUMAB ANTIBODIES (ADL)
View exact technical-name matches →
PT: ANTICORPOS ANTI-ADALIMUMAB (ADL)
Commercial name
Quantum Blue® Anti-Adalimumab
View exact commercial-name matches →
Risk class
Class II
Registration details
Registration Number
80102512669
Process Number
25351528460202181
CNPJ
04718143000194
Company information
Registration Holder
VR MEDICAL IMPORTADORA E DISTRIBUIDORA DE PRODUTOS MÉDICOS LTDA
Manufacturer
BUHLMANN LABORATORIES AG
Manufacturing Country
Switzerland
PT: SUÍÇA
Dates and status
Publication Date
Jun 10, 2021
Validity
VIGENTE
Last Updated
08/18/2026 19:00:00
About this record

Access comprehensive regulatory information for ANTI-ADALIMUMAB ANTIBODIES (ADL) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80102512669 and manufactured by BUHLMANN LABORATORIES AG. The registration is held by VR MEDICAL IMPORTADORA E DISTRIBUIDORA DE PRODUTOS MÉDICOS LTDA with validity until currently active (VIGENTE).

This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.